Insider · CIK 0002125562
Charles Nolan Parker
Files at TRAW (Traws Pharma, Inc.). First filing -, latest -.
In brief
Charles Nolan Parker files SEC Form 4 as CFO at TRAW (Traws Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles Nolan Parker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Jul 14, 2026 |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Common Stock | +15,393 | $0.00 | $0 | 15,393 | Apr 8, 2026 |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +32,406 | $0.00 | $0 | 32,406 | Apr 8, 2026 |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +61,571 | $0.00 | $0 | 61,571 | Apr 8, 2026 |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +104,544 | $0.00 | $0 | 104,544 | Apr 8, 2026 |
Questions about Charles Nolan Parker
Answered from the filings on this page, as of the latest one.
Is Charles Nolan Parker buying or selling?
Charles Nolan Parker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles Nolan Parker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles Nolan Parker has 0.
Where does Charles Nolan Parker file Form 4?
Charles Nolan Parker has filed Form 4 at TRAW (Traws Pharma, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.